Pyripyropene A Biosynthesis via Recombinant Microorganism Pathway Engineering

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing pyripyropene A are limited in efficiency and scalability, as they rely on specific fungal strains and complex biosynthetic pathways that are difficult to manipulate and scale up.

Innovation Solution

A method involving the culture of microorganisms with introduced polynucleotides or recombinant vectors that encode specific amino acid sequences, allowing for the biosynthesis of pyripyropene A through intermediate compounds, using plasmids like pPP6, pPP7, and pPP9 to facilitate gene recombination and enhance production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional fungal strain culture methods are used for pyripyropene A production, then the biosynthetic pathway can be maintained, but the production efficiency and scalability are limited

Engineering Contradiction:
Improveproduction efficiencyVSAvoidbiosynthetic pathway complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent segments the complex biosynthetic pathway into individual gene components (polyketide synthase, prenyltransferase, cyclase genes) that can be independently manipulated and optimized. This allows each segment to be engineered separately for improved efficiency while maintaining overall pathway functionality.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent employs parameter changes by modifying nucleotide sequences and amino acid sequences of biosynthetic genes to optimize enzyme activity and product yield. This includes altering gene expression levels, enzyme kinetics, and pathway flux parameters to enhance productivity.

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If specific fungal strains are used for pyripyropene A production, then the natural biosynthetic pathway is preserved, but the scalability and ease of manipulation are difficult

Engineering Contradiction:
Improveease of manipulationVSAvoidscalability
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The patent creates copies of biosynthetic genes and transfers them into host microorganisms through recombinant DNA technology. This allows the biosynthetic pathway to be replicated in scalable systems while maintaining the original pathway's functionality and enabling easier manipulation through genetic engineering.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent develops a universal recombinant vector system that can be applied across different microorganism hosts. This multi-functional platform enables the same biosynthetic pathway to be implemented in various organisms, improving ease of manipulation and scalability simultaneously.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Quantity of substance

If complex biosynthetic pathways are used for pyripyropene A synthesis, then the complete pathway is maintained, but the yield and production simplicity are reduced

Engineering Contradiction:
ImproveyieldVSAvoidproduction process complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent extracts key biosynthetic genes from the complex natural pathway and isolates them for independent expression in engineered hosts. This extraction allows for simplified production systems that maintain high yield by focusing on the essential pathway components while removing unnecessary complexity.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the efficient and scalable production of pyripyropene A, overcoming the limitations of traditional methods by utilizing genetic engineering to control the biosynthetic pathway, thereby increasing yield and simplifying the production process.

Implementation Method 1

a method for producing pyripyropene A, which comprises culturing a microorganism in which a polynucleotide or a recombinant vector comprising the polynucleotide is introduced with an intermediate compound necessary for the biosynthesis of pyripyropene A

Methodology Applied
Scientific EffectBiosynthesis: Fermentation

Data Source

PatentEP2530164B1Method for manufacturing a pyripyropene
Publication Date: 2017.08.09 MEIJI SEIKA KAISHA LTD
  • EP2530164B1 patent drawingFigure 1~3
  • EP2530164B1 patent drawingFigure 4~5
  • EP2530164B1 patent drawingFigure 6~7

AI summary

There is provided a method for culturing a microorganism in which a particular polynucleotide or a recombinant vector comprising it/them is introduced with an intermediate compound necessary for biosynthesis of pyripyropene A. The method of the present invention allows for the production of pyripyropene.